BPC-157
Also known as: Body Protection Compound-157, Body Protective Compound 157, PL 14736, Bepecin, pentadecapeptide BPC 157
BPC-157 is a synthetic pentadecapeptide, meaning a chain of 15 amino acids. Its sequence was derived from a fragment of a protein found in human gastric juice, and it was first described by researchers at the University of Zagreb in the 1990s. It does not occur in this exact form in nature and is produced by chemical synthesis.
Often sold in blends: Wolverine, Glow, Klow.
How it works
In animal models, researchers have reported that BPC-157 appears to influence blood vessel formation, interact with nitric oxide pathways, and affect growth factor signaling involved in tissue repair. These mechanisms are described from preclinical laboratory and animal work. How BPC-157 behaves in the human body has not been well characterized in published human studies.
Researched uses
- Studied in animals for tendon and ligament injury repair
- Studied in animals for muscle and bone healing
- Studied in animals for gastrointestinal conditions including inflammatory bowel and ulcer models
- Studied in animals for wound healing
- Studied in small human pilot reports for joint and musculoskeletal pain
- Studied in preliminary work for gut and mucosal protection
BPC-157 is not approved by the FDA for any use. There is no FDA-approved branded product. It is not on the FDA's list of bulk substances permitted for pharmacy compounding. It was previously placed in the FDA's 503A "Category 2" (substances raising significant safety concerns); that nomination was withdrawn in 2026 and the compound remains under regulatory review rather than authorized. Products sold online as BPC-157 "for research use only" are unregulated and fall outside the licensed pharmacy system. BPC-157 also appears on the World Anti-Doping Agency (WADA) Prohibited List, so it is banned in competitive sport.
BPC-157 providers compared
Providers that have passed our rubric review are listed first, then ordered by the total cost of a 3-month protocol. We average every cost to a standard 3-month protocol, which our medical advisors consider the best basis for comparing cost and value, and the headline figure folds in any one-time consult or provider-review fee plus three months of membership. Use the calculator below to adjust the length and see the same total broken out.
| Provider | Sourcing | What's included | Verified | Visit provider | |
|---|---|---|---|---|---|
RxPepsDirectVerified BPC-157 | 503A pharmacy | $279 for 3 months (est.) ≈3 vials · $80/vial incl. $39 consult | Consult fee extra · no membership | Jul 8, 2026 vial price | View |
Valhalla VitalityVerified BPC-157 Therapy (Injectable & Oral) | 503A pharmacy | $533 for 3 months (est.) ≈3 vials · $177.68/vial | No consult fee · no membership | Jul 9, 2026 vial price | View |
We average every cost to a standard 3-month protocol, which our medical advisors consider the best window for comparing cost and value. Monthly plans are multiplied by 3 and 3-month programs are taken as billed; each provider's own sticker price and cadence are shown underneath.
The headline figure is the total 3-month cost: the medication plus any one-time consult or provider-review fee (for example RxPepsDirect's $39) and three months of any membership fee. Where a fee is not published we fold in what is known and flag that other fees may apply.
Per-vial providers are averaged to a 3-month protocol at roughly one vial per month (3 vials), marked "est.", with the per-vial price shown underneath. Actual vial count depends on your dose and protocol.
Prices are gathered from each provider's public pages. The "Verified" date is when we last checked the provider's sticker price; for per-vial providers it is the vial price that was verified, not the averaged 3-month total.
Value check: total cost of therapy
This is the real value comparison. A sticker price hides consult and membership fees, so this adds everything up for a full protocol of BPC-157 and ranks by true total cost. We default to a 3-month protocol, the window our medical advisors consider best for judging value.
Per-vial providers are estimated at about one vial per month (3 vials for 3 months), plus any one-time consult. Actual vial count depends on your dose and protocol, so the real cost may run higher or lower.
Safety notes
The safety of BPC-157 in humans has not been established. Most safety data comes from animal studies, and published human data is limited to a small number of pilot reports; no large randomized controlled trial has established a safe dose or long-term safety profile. Because BPC-157 is not made or dispensed through the licensed pharmacy system, products marketed as "research use only" have not been verified for identity, purity, or sterility, and testing has found peptide products that were contaminated or mislabeled.
In the news
- Inside the booming, gray-market world of injectable peptides The Hill
Reporting on the gray market for research-use-only injectable peptides sold outside the licensed pharmacy system, and the associated health concerns.
BPC-157 questions
How much does BPC-157 cost?
Across the licensed providers tracked here, a full 3-month protocol of BPC-157 totals $279 to $533, depending on the provider, dose, and what is included. We average every cost to a standard 3-month protocol, which our medical advisors consider the best basis for comparing cost and value, and the total folds in any one-time consult or provider-review fee and three months of membership. The providers listing BPC-157 sell it by the vial, so the 3-month figure is an estimate of about one vial per month; the exact vial count depends on your dose and protocol. Each price shows the date the provider's sticker price was verified.
Is BPC-157 approved by the FDA?
No. BPC-157 is not approved by the FDA for any use, and there is no FDA-approved branded product. It is considered investigational, and most of the research to date has been in animals rather than in humans.
Can I get BPC-157 from a compounding pharmacy?
BPC-157 is not on the FDA's list of bulk substances permitted for pharmacy compounding. It was flagged over safety concerns and remains under regulatory review. Products advertised online as BPC-157 'for research use only' are sold outside the licensed pharmacy system and are not regulated for quality or safety.
What does the research actually show?
Preclinical animal studies have reported effects on tissue repair across several organ systems. Human evidence is limited to a few small pilot studies, and no completed, published randomized controlled trial has confirmed effectiveness for any use. The state of the evidence is best described as early and unproven in humans.
Related reading
- How to check that a peptide pharmacy is actually licensedA practical walkthrough of state board lookups, the difference between 503A and 503B pharmacies, and the warning signs that separate a real licensed pharmacy from a research-chemical seller.
- Peptide Therapy vs TRT: An Honest ComparisonAn independent, evidence-honest look at how TRT and peptide therapy differ on FDA status, research, fertility, safety, and finding legal, prescription-based care.
- How to Get Peptides Safely and LegallyHow to get peptides through the legal, licensed pathway: prescriptions, 503A/503B pharmacies, honest evidence, and how to avoid the research-use-only gray market.
- Is Peptide Therapy Right for You?An independent guide to weighing peptide therapy: legality, what the research actually shows, who should avoid it, and how to find safe, licensed care.
- Peptides Studied for Longevity and Anti-AgingAn independent look at peptides studied for longevity (GHK-Cu, epithalon, MOTS-c, humanin), what the research shows, and how to find safe, legal care.
- Peptides Studied for Joint Pain and RecoveryWhat research shows on BPC-157 and TB-500 for joint pain and recovery, the evidence limits, legality, and how to find safe, licensed care.
- Peptides Studied for Gut HealthAn independent look at BPC-157 and KPV for gut health: what the animal research shows, why neither is FDA-approved, and how to stay in the regulated system.
- Peptide Access in 2026: What's Legal, What's RestrictedAn independent look at peptide access in 2026: which compounds are legal, which are restricted, what the evidence shows, and how to find licensed treatment.
- Peptide Therapy Side Effects: An Evidence-Based GuideAn independent, evidence-based look at peptide therapy side effects by compound class, gray-market supply risk, and how to find safe, legal treatment.